Metoprolol "gea"

Metoprolol, the active ingredient in Metoprolol "gea", is a beta blocker presented as an oral tablet for oral use. It is employed to lower elevated blood pressure and to manage various cardiovascular conditions such as angina, heart failure, and post‑myocardial infarction in adult patients. It is commonly prescribed in adult populations.

GNH USA supplies Metoprolol "gea" as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable global logistics.

Metoprolol is a selective β1‑adrenergic blocker used in the management of cardiovascular disorders. - Hypertension: reduces systemic blood pressure by decreasing cardiac output. - Angina pectoris: lowers myocardial oxygen demand, relieving chest pain. - Heart failure: improves survival and reduces hospitalizations by decreasing workload on the heart. - Post‑myocardial infarction: lowers risk of recurrent events and arrhythmias. - Cardiac arrhythmias: controls heart rate in certain supraventricular tachyarrhythmias.

Metoprolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headed sensation, especially when standing quickly. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea, abdominal discomfort. - Depression: mood changes or low mood.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Heart block: impaired electrical conduction in the heart. - Hypotension: dangerously low blood pressure. - Bronchospasm: narrowing of airways, especially in asthmatic patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiogenic shock: acute failure of the heart to pump effectively.

Before initiating therapy, several safety considerations should be observed. - Monitor blood pressure: ensure adequate control and avoid excessive lowering. - Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. - Use caution in asthma or COPD: β1‑selectivity may still affect bronchial tone. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia. - Store at room temperature: keep in the original container, protect from moisture.

Metoprolol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Other beta blockers: additive cardiac depression. - Calcium channel blockers (verapamil, diltiazem): may cause severe bradycardia or AV block. - Antiarrhythmics (amiodarone, sotalol): increase risk of conduction abnormalities. - Clonidine: abrupt withdrawal can precipitate hypertensive crisis. - MAO inhibitors: may enhance hypotensive effects.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive effect. - Antidiabetic agents: may mask hypoglycemia symptoms. - Antidepressants (SSRIs, SNRIs): potential for additive bradycardia. - Diuretics: may increase risk of electrolyte imbalance. - Digoxin: heightened risk of bradyarrhythmias.